Product code NHT— Microbiology

ANTHRACIS REAL-TIME PCR ASSAY

Classification name
Assay, Nucleic Acid Amplification, Bacillus Anthracis
Device class
Class 2
Regulation
21 CFR 866.3045
Advisory panel
Microbiology
Total cleared
6
First cleared
Most recent

FDA classification definition

“An invitro diagnostic device used to presumptively detect the presence or absence of b. Anthracis directly in blood specimens or suspicious culture growth.”

— U.S. Food and Drug Administration, device classification record for product code NHT under 21 CFR 866.3045, via openFDA

Market context for product code NHT

FDA has cleared 6 devices under product code NHT between 2005 and 2019, filed by 4 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

Top applicants under product code NHT

Recent clearances under product code NHT

Data sourced from openFDA. This site is unofficial and independent of the FDA.